CTHRepealedLegislation
National Health (Chemotherapy Pharmaceuticals Access Program) Special Arrangement 2010 (No. PB 117 of 2010)
Sch 1Pharmaceutical benefits covered by this Special Arrangement and related information
Start here
Get a plain-English read of Sch 1
Turn the raw legal text into a practical explanation grounded in National Health (Chemotherapy Pharmaceuticals Access Program) Special Arrangement 2010 (No. PB 117 of 2010).
Schedule 1 Pharmaceutical benefits covered by this Special Arrangement and related information
(sections 5, 7, 8, 9, 12, 17, 18, 20 and 22)
| Listed Drug | Form | Manner of Administration | Brand | Responsible Person | Authorised Prescriber | Circumstances | Purposes | Maximum Quantity | Number of Repeats | Section 100 only |
|---|---|---|---|---|---|---|---|---|---|---|
| Aprepitant | Pack containing 1 capsule 125 mg and 2 capsules 80 mg | Oral | Emend | MK | EMP | C3619 C3620 C3621 | 1 | 5 | ||
| Arsenic | Injection concentrate containing arsenic trioxide 10 mg in 10 mL | Injection | Phenasen | PL | EMP | C3150 | 60 | 2 | ||
| "BCG Immunotherapeutic" (Bacillus Calmette-Guérin/ Connaught strain) | Powder for intravesical administration containing 6.6 to 19.2 x 10 8 CFU | Intravesical | ImmuCyst | SW | EMP | C1419 | 3 | 1 | ||
| "BCG-Tice" (Bacillus Calmette-Guérin/ Tice strain) | Vial containing powder for intravesical administration approximately 5 x 10 8 CFU | Intravesical | OncoTICE | MK | EMP | C1290 | 3 | 1 | ||
| Bevacizumab | Solution for I.V. infusion 100 mg in 4 mL | Injection | Avastin | RO | EMP | C3430 C3431 | 1 | 0 | ||
| Solution for I.V. infusion 400 mg in 16 mL | Injection | Avastin | RO | EMP | C3430 C3431 | 1 | 0 | |||
| Bleomycin | Powder for injection containing bleomycin sulfate 15,000 I.U. (with any determined brand of sodium chloride injection as the required solvent) | Injection | Hospira Pty Limited | HH | EMP |